Analysis of binding of β-glucan to mouse peripheral blood leukocytes

Biotherapy

Volumn 19, Issue 2, 2005, Pages 197-203

  Suga, Yasuyo ^a   Murata, Masahiro ^a   Suga, Tetsuya ^a  

^a AJINOMOTO CO INC   (Japan)

Author keywords

1,3 glucan (lentinan); Anti tumor effects; Dextran; Lentinan binding

Indexed keywords

BETA 1,3 GLUCAN; BETA 1,6 GLUCAN; BETA GLUCAN; LENTINAN; TEGAFUR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BINDING; GRANULOCYTE; LENTINUS EDODES; LEUKOCYTE; MONOCYTE; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN BINDING; STRUCTURE ACTIVITY RELATION;

EID: 17644380556     PISSN: 09142223     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hamuro, J., Hadding, U. and Bitter-Suermann, D.: Solid phase activation of alternative pathway of complement bete-1,3-glucans and its possible role for tumour regressing activity. Immunology 34:695-705, 1978.
2. Brown, G.D. and Gordon, S.: A new receptor for β-glucan. Nature 413: 36-37, 2001.
3. Oka, M., Hazama, S., Suzuki, T., et al.: In vitro and in vivo analysis of human leukocyte binding by the antitumor polysaccharide, lentinan. Int. J. Immunopharmacol. Immunotoxicol. 18(3): 211-216, 1996.
4. th Annual Meeting, 1991.
5. Kishida, E., Sone, Y., Misaki, A., et al.: Preparation and immunochemical characterization of antibody to branched β-(1-3)-D-glucan of Volvariella volvacea, and its use in studies of antitumor actions. Agric. Biol. Chem. 53(7): 1849-1859, 1989.
6. Vetvicka, V., Thornton, B.P. and Ross, G.D.: Soluble β-glucan polysaccharide binding to the lectin site of neutrophil or NK cell complement receptor type 2 (CD11/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J. Clin. Invest. 98(1): 50-61, 1996.
7. Thronton, B.P., Vetvicka, V., Ross, G.D., et al.: Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 156: 1235-1246, 1996.
8. Kanbe, E., Emi, N., Saito, H., et al.: Novel synthesized trimannose conjugate induces endocytosis and expression of immunostimulatory molecules in monocytic leukemia cells. Int. J. Hematol. 74: 309-315, 2001.
9. Brown, G.D., Taylor, P.R., Gordon, S., et al.: Dectin-1 is a major β-glucan receptor on macrophages. J. Exp. Med. 196(3): 407-412, 2002.
10. Takeda, K., Kaisho, T. and Akira, S.: Toll-like receptors. Annu. Rev. Immunol. 23: 335-376, 2003.
11. Gantner, B.N., Simmons, R.M., Underhill, D.M., et al.: Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor. J. Exp. Med. 197(9): 1107-1117, 2003.
12. Suga, T., Shiio, T., Chihara, G., et al.: Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis. Cancer Res. 44: 5132-5137, 1984.
13. Poltorak, A., He, X., Beutler, B., et al.: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088, 1999.
14. Takeuchi, O., Kawai, T., Akira, S., et al.: Discrimination og bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13: 933-940, 2001.
15. Underhill, D.M., Ozinsky, A., Aderem, A., et al.: The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401: 811-815, 1999.